Page 174 of 188 · 5,620 total

patent null · Mar 5, 2024

Uber Technologies, Inc. v.Enovsys, LLC

· IPR2024-00827

Uber Technologies filed a Petition challenging the validity of Enovsys's Proximity Alert Patent (6756918) based on obviousness (35 U.S.C. § 103). The petitioner argues that existing prior art, including Layson references and Taylor/Fast teachings, renders the claimed location tracking methods unpatentable. This challenges a key patent in the victim-offender monitoring space.

patent instituted · Mar 5, 2024

Juniper Networks, Inc. v.Portsmouth Network Corporation

· IPR2024-00893

The PTAB granted institution for an IPR concerning network reconfiguration protocols, finding a reasonable likelihood of prevailing on the grounds of obviousness (103). The patent relates to methods for rapid link failure recovery in Switching/Routing Protocols (STP).

patent instituted · Mar 5, 2024

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00853

Abbott Diabetes Care successfully petitioned to institute IPR proceedings against DexCom for patent infringement related to remote patient monitoring and glucose technology. The Board found a reasonable likelihood of prevailing on multiple grounds, specifically finding that prior art combinations rendered key claims obvious under 35 U.S.C. § 103.

patent instituted · Mar 5, 2024

Abbott Diabetes Care Inc. et al. v.DexCom, Inc.

· IPR2024-00840

Abbott Diabetes Care Inc. successfully petitioned to challenge DexCom's CGM patent (9119528) on grounds of anticipation and obviousness over Brauker. The Board found a reasonable likelihood of unpatentability for the challenged claims, leading to institution.

patent denied · Mar 5, 2024

Uber Technologies, Inc. v.Enovsys, LLC

· IPR2024-00827

The PTAB denied institution of an IPR challenging claims related to location tracking and wireless systems. The Board found insufficient evidence that the challenged claims would be obvious over the cited prior art, particularly regarding specific limitations like 'tracking period' or 'tracking request.'

patent denied · Mar 5, 2024

Uber Technologies, Inc. v.Envosys, LLC

· IPR2024-00825

Uber Technologies' IPR challenge against Envosys' location tracking patent was denied by the PTAB. The Board found that the petitioner failed to meet the burden of showing a reasonable likelihood of prevailing, particularly regarding the scope of geographic notification limitations.

patent Final Written Decision · Mar 5, 2024

Juniper Networks, Inc. v.Portsmouth Network Corporation

· IPR2024-00893

The PTAB issued a Final Written Decision finding several claims of the '986 patent unpatentable under 35 U.S.C. § 103(a). The Board concluded that the combination of prior art references, including Gai and an IEEE publication, taught the full scope of the claimed network failure recovery method.

patent null · Mar 4, 2024

Dyson Technology Limited et al. v.Omachron Intellectual Property Inc. et al.

· IPR2024-00766

Dyson challenges Omachron's surface cleaning vacuum patent (10,568,477) in an IPR, asserting that the claims are obvious under 35 U.S.C. §103. The petition relies heavily on prior art references Dimbylow/Howes and Brown/Vuijk to demonstrate obviousness across multiple claim sets.

patent null · Mar 4, 2024

NEURENT MEDICAL INC. et al. v.The Foundry, LLC et al.

· IPR2024-00669

The petitioner asserts that U.S. Patent No. 11,679,077 is invalid due to anticipation and obviousness over multiple prior art references in the field of nasal therapy. The core arguments focus on how Saadat anticipates key claims, while combinations of Makower, Fang, and Edwards-535 render other claims obvious.

patent denied · Mar 4, 2024

Dyson Technology Limited et al. v.Omachron Intellectual Property Inc. et al.

· IPR2024-00766

The PTAB denied Dyson's IPR challenge against Omachron's vacuum cleaner patent (10,568,477). The Board found that the Petitioner failed to demonstrate a reasonable likelihood of success, rejecting arguments based on prior art references like Brown and Dimbylow.

patent instituted · Mar 4, 2024

NEURENT MEDICAL INC. et al. v.The Foundry, LLC et al.

· IPR2024-00669

NEURENT MEDICAL INC. successfully petitioned PTAB for institution of IPR against THE FOUNDRY, LLC's nasal cavity treatment patent (11679077). The Board found sufficient evidence across multiple grounds of anticipation and obviousness to proceed to trial.

patent Final Written Decision · Mar 4, 2024

NEURENT MEDICAL INC. et al. v.The Foundry, LLC et al.

· IPR2024-00669

The Petitioner successfully demonstrated that multiple claims of the '077 patent were unpatentable over various combinations of prior art references. The Board found that a Person Having Ordinary Skill in the Art (POSA) would have been motivated to combine existing RF ablation and nasal treatment technologies.

patent instituted · Mar 2, 2024

Monolithic Power Systems, Inc. v.Greenthread, LLC

· IPR2024-00469

Monolithic Power Systems successfully obtained institution of an IPR against Greenthread’s 9,190,502 patent covering graded‑dopant semiconductor devices. The Board found a reasonable likelihood of unpatentability on claims 7 and 8 based on obviousness over Onoda, Nishizawa, and Kawagoe. The proceeding now moves to trial.

patent denied · Mar 2, 2024

Monolithic Power Systems, Inc. v.Greenthread, LLC

· IPR2024-00468

Monolithic Power Systems filed a response opposing Greenthread’s request for Director Review of a PTAB decision that found the ’195 patent claims unpatentable. The petitioner contends the Board correctly applied prosecution history and that the request merely repeats arguments already rejected in multiple IPRs.

patent · Mar 2, 2024

Monolithic Power Systems, Inc. v.Greenthread, LLC

· IPR2024-00469

Monolithic Power Systems filed a Director Review request challenging the PTAB’s claim construction and obviousness finding for its MOSFET doping‑profile patent (U.S. 9,190,502). The petitioner argues the Board misinterpreted functional claim language and ignored district‑court rulings, asserting that the cited references do not teach the required carrier‑movement limitation.

patent null · Mar 2, 2024

Monolithic Power Systems, Inc. v.Greenthread, LLC

· IPR2024-00469

Monolithic Power Systems challenged U.S. Patent No. 9,190,502 regarding semiconductor device claims (7 and 8) in an IPR proceeding. The Petitioner argues that the claimed graded dopant profiles and electric drift fields are obvious over prior art references like Onoda and Kawagoe. The Board has instituted the case for trial, finding the evidence compelling enough to proceed with the challenge.

patent · Mar 1, 2024

US Conec Ltd. v.Senko Advanced Components, Inc.

· IPR2024-00119

US Conec Ltd. and Senko Advanced Components have settled their IPR over U.S. Patent 11,415,760 and jointly request that the settlement be kept confidential while moving to terminate the proceeding.

patent · Mar 1, 2024

US Conec Ltd. v.Senko Advanced Components, Inc.

· IPR2024-00119

Senko Advanced Components argues that US Conec’s IPR petition fails because the cited prior art does not qualify under §102 or disclose the required “slidably received” groove features of claim 1. The patent owner seeks denial of the petition.

patent · Mar 1, 2024

US Conec Ltd. v.Senko Advanced Components, Inc.

· IPR2024-00119

Senko Advanced Components submits a sur‑reply defending its ownership of U.S. Patent 11,415,760 against US Conec Ltd.’s IPR petition. The Owner emphasizes that a pre‑CIP assignment transferred all rights, including continuations‑in‑part, and that the challenger failed to prove the Wong patent qualifies as prior art.

patent terminated or settled · Mar 1, 2024

US Conec Ltd. v.Senko Advanced Components, Inc.

· IPR2024-00119

US Conec and Senko Advanced Components entered a settlement that led to the joint termination of multiple IPR proceedings, including the patent covering 11,415,760. The Board granted the termination and partially approved confidentiality of the settlement agreement.

patent instituted · Mar 1, 2024

JIANGSU FAVORED NANOTECHNOLOGY CO., LTD. v.P2i Ltd.

· IPR2024-00380

JIANGSU FAVORED NANOTECHNOLOGY CO., LTD. successfully petitioned to challenge P2i Ltd.'s patent (11041087) before the PTAB, leading to institution of the IPR. The petitioner alleges that the polymer coating claims are obvious over combinations of prior art references like Cohen and Legein.

patent instituted · Mar 1, 2024

JIANGSU FAVORED NANOTECHNOLOGY CO., LTD. v.P2i Ltd.

· IPR2024-00380

JIANGSU FAVORED NANOTECHNOLOGY CO., LTD. successfully petitioned to overturn a discretionary denial of IPR for P2i Ltd.'s patent (11041087). The Board found that the prior art was sufficiently evaluated during prosecution, leading to the institution of the case on § 103 grounds.

patent denied · Mar 1, 2024

Panasonic Automotive Systems Co., Ltd. v.UNM Rainforest Innovations

· IPR2024-00364

The PTAB denied institution of an IPR challenge against UNM Rainforest Innovations' patent 8265096, finding no reasonable likelihood that the petitioner could prove unpatentability. The denial hinged on the Board's rejection of anticipation arguments based on prior art related to wireless data formats.

patent final · Mar 1, 2024

JIANGSU FAVORED NANOTECHNOLOGY CO., LTD. v.P2i Ltd.

· IPR2024-00380

The PTAB found the challenged claims unpatentable over prior art based on obviousness (35 U.S.C. § 103). The Board determined that combining references like Cohen and Legein, or Francesch and Legein, was motivated by intrinsic evidence and skilled artisan capabilities. This decision significantly impacts the patent owner's portfolio in plasma polymerization coatings for electronics.

patent · Mar 1, 2024

US Conec Ltd. v.Senko Advanced Components, Inc.

· IPR2024-00119

US Conec Ltd. challenged 17 claims of Senko Advanced Components, Inc.'s patent using grounds of anticipation (102) and obviousness (103). The petitioner argues that the claimed optical fiber connectors are rendered obvious by various combinations of prior art references like Raven, Kuffel, Wong, and Gniadek. The case was dismissed without a final ruling due to a stipulation not to pursue district court grounds.

patent · Feb 29, 2024

Inari Agriculture, Inc. v.Pioneer Hi-Bred International, Inc.

· PGR2024-00019

Inari Agriculture challenges the PTAB’s denial of its PGR, arguing the Board improperly required seed sequencing under §103 for a plant utility patent. The petition seeks director review to overturn the denial and restore the ability to contest the patent without analyzing deposited seed.

patent denied · Feb 29, 2024

Inari Agriculture, Inc. v.Pioneer Hi-Bred International, Inc.

· PGR2024-00019

The USPTO Director denied Inari Agriculture's request for a Director Review of the PTAB's institution denial, leaving Pioneer Hi‑Bred's seed patent intact.

patent · Feb 29, 2024

Samsung Austin Semiconductor, LLC et al. v.Sung, Chien-Min

· IPR2024-00535

Samsung submits an authorized response to the Patent Owner’s Director Review request, defending the Board’s findings that the ’802 patent’s claims are valid and that prior art references, including Sung’146, are properly considered. The petitioner seeks denial of the review.

patent · Feb 29, 2024

Samsung Austin Semiconductor, LLC et al. v.Sung, Chien-Min

· IPR2024-00535

Samsung seeks to invalidate a CMP‑pad dresser patent (U.S. 9,138,862) by alleging that prior‑art references, especially Sung’026 and related disclosures, anticipate or render obvious all 20 claims. The petition argues public accessibility of the prior art and cites discretionary factors favoring institution.

patent · Feb 29, 2024

Samsung Austin Semiconductor, LLC et al. v.Sung, Chien-Min

· IPR2024-00535

Samsung’s IPR against Chien‑Min Sung’s 9,724,802 patent was decided with claims 1‑9 and 12‑21 found unpatentable. The patent owner now petitions the Director to overturn the Board’s findings, arguing errors in the designated‑profile analysis, ignored expert testimony, and improper priority treatment of Sung ’146.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →